347 related articles for article (PubMed ID: 11122106)
1. Expression of tumour necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptors and sensitivity to TRAIL-induced apoptosis in primary B-cell acute lymphoblastic leukaemia cells.
Clodi K; Wimmer D; Li Y; Goodwin R; Jaeger U; Mann G; Gadner H; Younes A
Br J Haematol; 2000 Nov; 111(2):580-6. PubMed ID: 11122106
[TBL] [Abstract][Full Text] [Related]
2. Role of antiapoptotic proteins in tumor necrosis factor-related apoptosis-inducing ligand and cisplatin-augmented apoptosis.
Kim JH; Ajaz M; Lokshin A; Lee YJ
Clin Cancer Res; 2003 Aug; 9(8):3134-41. PubMed ID: 12912965
[TBL] [Abstract][Full Text] [Related]
3. Sensitization to TRAIL-induced apoptosis and modulation of FLICE-inhibitory protein in B chronic lymphocytic leukemia by actinomycin D.
Olsson A; Diaz T; Aguilar-Santelises M; Osterborg A; Celsing F; Jondal M; Osorio LM
Leukemia; 2001 Dec; 15(12):1868-77. PubMed ID: 11753607
[TBL] [Abstract][Full Text] [Related]
4. Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes.
Leverkus M; Neumann M; Mengling T; Rauch CT; Bröcker EB; Krammer PH; Walczak H
Cancer Res; 2000 Feb; 60(3):553-9. PubMed ID: 10676636
[TBL] [Abstract][Full Text] [Related]
5. Enhanced caspase-8 recruitment to and activation at the DISC is critical for sensitisation of human hepatocellular carcinoma cells to TRAIL-induced apoptosis by chemotherapeutic drugs.
Ganten TM; Haas TL; Sykora J; Stahl H; Sprick MR; Fas SC; Krueger A; Weigand MA; Grosse-Wilde A; Stremmel W; Krammer PH; Walczak H
Cell Death Differ; 2004 Jul; 11 Suppl 1():S86-96. PubMed ID: 15105837
[TBL] [Abstract][Full Text] [Related]
6. Ultraviolet light downregulates CD95 ligand and TRAIL receptor expression facilitating actinic keratosis and squamous cell carcinoma formation.
Bachmann F; Buechner SA; Wernli M; Strebel S; Erb P
J Invest Dermatol; 2001 Jul; 117(1):59-66. PubMed ID: 11442750
[TBL] [Abstract][Full Text] [Related]
7. Induction and intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) mediated apotosis in human malignant glioma cells.
Hao C; Beguinot F; Condorelli G; Trencia A; Van Meir EG; Yong VW; Parney IF; Roa WH; Petruk KC
Cancer Res; 2001 Feb; 61(3):1162-70. PubMed ID: 11221847
[TBL] [Abstract][Full Text] [Related]
8. TRAIL-induced eradication of primary tumour cells from multiple myeloma patient bone marrows is not related to TRAIL receptor expression or prior chemotherapy.
Lincz LF; Yeh TX; Spencer A
Leukemia; 2001 Oct; 15(10):1650-7. PubMed ID: 11587225
[TBL] [Abstract][Full Text] [Related]
9. Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity.
Mirandola P; Ponti C; Gobbi G; Sponzilli I; Vaccarezza M; Cocco L; Zauli G; Secchiero P; Manzoli FA; Vitale M
Blood; 2004 Oct; 104(8):2418-24. PubMed ID: 15205263
[TBL] [Abstract][Full Text] [Related]
10. Relation of TNF-related apoptosis-inducing ligand (TRAIL) receptor and FLICE-inhibitory protein expression to TRAIL-induced apoptosis of melanoma.
Zhang XD; Franco A; Myers K; Gray C; Nguyen T; Hersey P
Cancer Res; 1999 Jun; 59(11):2747-53. PubMed ID: 10364001
[TBL] [Abstract][Full Text] [Related]
11. TRAIL-induced signalling and apoptosis.
MacFarlane M
Toxicol Lett; 2003 Apr; 139(2-3):89-97. PubMed ID: 12628743
[TBL] [Abstract][Full Text] [Related]
12. Chemical sensitization and regulation of TRAIL-induced apoptosis in a panel of B-lymphocytic leukaemia cell lines.
Kang J; Kisenge RR; Toyoda H; Tanaka S; Bu J; Azuma E; Komada Y
Br J Haematol; 2003 Dec; 123(5):921-32. PubMed ID: 14632785
[TBL] [Abstract][Full Text] [Related]
13. TNF-related apoptosis-inducing ligand (TRAIL) frequently induces apoptosis in Philadelphia chromosome-positive leukemia cells.
Uno K; Inukai T; Kayagaki N; Goi K; Sato H; Nemoto A; Takahashi K; Kagami K; Yamaguchi N; Yagita H; Okumura K; Koyama-Okazaki T; Suzuki T; Sugita K; Nakazawa S
Blood; 2003 May; 101(9):3658-67. PubMed ID: 12506034
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic adenocarcinoma cell lines show variable susceptibility to TRAIL-mediated cell death.
Ibrahim SM; Ringel J; Schmidt C; Ringel B; Müller P; Koczan D; Thiesen HJ; Löhr M
Pancreas; 2001 Jul; 23(1):72-9. PubMed ID: 11451151
[TBL] [Abstract][Full Text] [Related]
15. TRAIL-induced apoptosis of thyroid cancer cells: potential for therapeutic intervention.
Ahmad M; Shi Y
Oncogene; 2000 Jul; 19(30):3363-71. PubMed ID: 10918593
[TBL] [Abstract][Full Text] [Related]
16. Expression of tumor necrosis factor-related apoptosis-inducing ligand, Apo2L, and its receptors in myelodysplastic syndrome: effects on in vitro hemopoiesis.
Zang DY; Goodwin RG; Loken MR; Bryant E; Deeg HJ
Blood; 2001 Nov; 98(10):3058-65. PubMed ID: 11698291
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility to TRAIL-induced apoptosis of acute leukemia cells in the context of TRAIL receptor gene expression and constitutive NF-kappa B activity.
Wuchter C; Krappmann D; Cai Z; Ruppert V; Scheidereit C; Dörken B; Ludwig WD; Karawajew L
Leukemia; 2001 Jun; 15(6):921-8. PubMed ID: 11417478
[TBL] [Abstract][Full Text] [Related]
18. How TRAIL kills cancer cells, but not normal cells.
Gura T
Science; 1997 Aug; 277(5327):768. PubMed ID: 9273698
[No Abstract] [Full Text] [Related]
19. Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells.
Zhang XD; Franco AV; Nguyen T; Gray CP; Hersey P
J Immunol; 2000 Apr; 164(8):3961-70. PubMed ID: 10754286
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis-mediating receptor-ligand systems in human retinal pigment epithelial cells.
Hueber A; Aduckathil S; Kociok N; Welsandt G; Dinslage S; Kirchhof B; Esser PJ
Graefes Arch Clin Exp Ophthalmol; 2002 Jul; 240(7):551-6. PubMed ID: 12136286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
